Zacks: Simulations Plus, Inc. (SLP) Given $18.00 Consensus Target Price by Brokerages
Shares of Simulations Plus, Inc. (NASDAQ:SLP) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Analysts have set a 12-month consensus target price of $18.00 for the company and are forecasting that the company will post $0.10 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Simulations Plus an industry rank of 163 out of 265 based on the ratings given to related companies.
A number of brokerages have recently weighed in on SLP. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a research note on Thursday, October 5th. Zacks Investment Research cut Simulations Plus from a “hold” rating to a “sell” rating in a research note on Friday, December 22nd.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its stake in Simulations Plus by 8.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 400,308 shares of the technology company’s stock worth $4,944,000 after purchasing an additional 32,114 shares in the last quarter. Northern Trust Corp grew its stake in Simulations Plus by 248.7% during the 2nd quarter. Northern Trust Corp now owns 145,018 shares of the technology company’s stock worth $1,791,000 after purchasing an additional 103,435 shares in the last quarter. State Street Corp grew its stake in Simulations Plus by 432.6% during the 2nd quarter. State Street Corp now owns 131,012 shares of the technology company’s stock worth $1,617,000 after purchasing an additional 106,412 shares in the last quarter. Cadence Capital Management LLC grew its stake in Simulations Plus by 5.1% during the 3rd quarter. Cadence Capital Management LLC now owns 116,304 shares of the technology company’s stock worth $1,803,000 after purchasing an additional 5,636 shares in the last quarter. Finally, OxFORD Asset Management LLP grew its stake in Simulations Plus by 471.6% during the 3rd quarter. OxFORD Asset Management LLP now owns 58,336 shares of the technology company’s stock worth $910,000 after purchasing an additional 48,131 shares in the last quarter. 33.56% of the stock is owned by hedge funds and other institutional investors.
Simulations Plus (NASDAQ SLP) remained flat at $$16.30 during trading hours on Thursday. 43,541 shares of the company’s stock were exchanged, compared to its average volume of 52,817. Simulations Plus has a fifty-two week low of $9.45 and a fifty-two week high of $17.45. The company has a market cap of $281.88, a PE ratio of 46.57 and a beta of -0.76.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Tuesday, November 14th. The technology company reported $0.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.05 by $0.01. Simulations Plus had a return on equity of 24.56% and a net margin of 23.78%. The business had revenue of $6.30 million during the quarter, compared to analysts’ expectations of $5.01 million. equities research analysts predict that Simulations Plus will post 0.39 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.watchlistnews.com/zacks-simulations-plus-inc-slp-given-18-00-consensus-target-price-by-brokerages/1807160.html.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.